Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Biomerica is a medical devices business based in the US. Biomerica stocks (BMRA.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $4.21 – a decrease of 15.69% over the previous week. Biomerica employs 66 staff and has a trailing 12-month revenue of around $14.6 million.
Finder's Pick for
Beginners
Finder's Pick for
Free Trades
Finder's Pick for
Commodity Stocks
Finder's Pick for
US Stocks
| Latest market close | $3.01 |
|---|---|
| 52-week range | $2.66 - $7.38 |
| 50-day moving average | $4.00 |
| 200-day moving average | $4.37 |
| Wall St. target price | $13.00 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-0.28 |
Note: The dollar amounts in the table below are in Canadian dollars.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the close of $3.01 from 2022-05-13
| 1 week (2022-05-05) | -19.73% |
|---|---|
| 1 month (2022-04-13) | -30.32% |
| 3 months (2022-02-16) | -31.12% |
| 6 months (2021-11-16) | -36.23% |
| 1 year (2021-05-14) | -15.21% |
|---|---|
| 2 years (2020-05-15) | -59.32% |
| 3 years (2019-05-16) | 33.78% |
| 5 years (2017-05-16) | 14.45% |
| Revenue TTM | $14.6 million |
|---|---|
| Gross profit TTM | $496,981 |
| Return on assets TTM | -14.25% |
| Return on equity TTM | -34.45% |
| Profit margin | -23.98% |
| Book value | $0.76 |
| Market capitalisation | $35.8 million |
TTM: trailing 12 months
We're not expecting Biomerica to pay a dividend over the next 12 months.
Biomerica's shares were split on a 1:2 basis on 13 November 1994. So if you had owned 2 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Biomerica shares – just the quantity. However, indirectly, the new 100% higher share price could have impacted the market appetite for Biomerica shares which in turn could have impacted Biomerica's share price.
Over the last 12 months, Biomerica's shares have ranged in value from as little as $2.66 up to $7.38. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Biomerica's is -0.675. This would suggest that Biomerica's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Biomerica has bucked the trend.
Biomerica, Inc. , a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various diseases and other medical complications; or to measure the level of specific bacteria, hormones, antibodies, antigens, or other substances, which exist in the patient's body and stools or blood in extremely small concentrations. It primarily sells its products for gastrointestinal diseases, food intolerances, diabetes, and various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also developing InFoods, an irritable bowel syndrome therapy technology and diagnostic-guided therapy; Helicobacter pylori products, as well as develops, tests, validates, and sells diagnostic products for COVID-19 infection. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California.
Here’s what you need to know about investing in the propane industry, including 3 popular propane stocks to watch.
Read more…
Using our proprietary algorithm, we’ve found the best blue chip stocks on the TSX, NYSE and Nasdaq based on price, performance and more.
Read more…
Want to invest in satellite companies? We’ve put together a list of 6 satellite stocks you should keep your eye on.
Read more…Everything we know about the Hanover Bancorp, Inc. IPO, plus information on how to buy in.
Everything we know about the PrimeBlock IPO, plus information on how to buy in.
Everything we know about the Actelis Networks IPO, plus information on how to buy in.
Everything we know about the ProFrac Holding Corp IPO, plus information on how to buy in.
Everything we know about the Wytec International IPO, plus information on how to buy in.
Here are some of the best stocks for inflation periods to reduce the negative impacts of inflation on your portfolio.
Choose from many account and investment types to invest in global markets, but expect to pay high commissions with HSBC InvestDirect, which doesn’t have an app.
Our Flahmingo review tells you how to buy fractional shares of some of your favourite US companies with as little as $1.
Steps to owning and managing EXPD stock, with 24-hour and historical pricing before you buy.
Steps to owning and managing PRU stock, with 24-hour and historical pricing before you buy.
